In patients with renal insufficiency associated with increased hemoglobin levels and polycythemia, the possibilities of recombinant erythropoietin overdosing and disorders such as neoplasms and ...

In the U.S., Vafseo® (vadadustat) is approved for the treatment of anemia due to CKD in adults who have been receiving dialysis for at least three months. Nephrologists in the U.S. began prescribing ...

Inadequate hemodialysis was a major cause of erythropoietin resistance in pediatric patients. Investigators have identified several risk factors associated with erythropoietin (EPO) resistance in ...